4//SEC Filing
Edwards Robert Grant 4
Accession 0001683168-20-001273
CIK 0001367083other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:17 PM ET
Size
5.1 KB
Accession
0001683168-20-001273
Insider Transaction Report
Form 4
Edwards Robert Grant
Chief Financial Officer
Transactions
- Award
Common Stock, $0.0001 par value
2020-04-23+2,609→ 2,609 total
Footnotes (1)
- [F1]The award will vest in three years, with the first third vesting on April 14, 2021, second third will vest on April 14, 2022 and remaining third will vest on April 14, 2023. If the Issuer terminates Mr. Edwards prior to April 14, 2021, all stock will vest immediately on the termination date. If the Issuer terminates Mr. Edwards on or after April 14, 2021, including by not renewing this agreement, all unvested stock will be forfeited. If Mr. Edwards terminates, all unvested stock will be forfeited.
Documents
Issuer
Sonoma Pharmaceuticals, Inc.
CIK 0001367083
Entity typeother
Related Parties
1- filerCIK 0001810327
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:17 PM ET
- Size
- 5.1 KB